Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)

The summary for the Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01): The purpose of this limited competition is to extend the activities of the ASSESS AKI consortium to continue an observational cohort of patients with normal renal function and with chronic kidney disease (CKD) who have had an episode of AKI and appropriate control participants to ascertain a) long-term renal functional outcomes, b) long-term cardiovascular disease outcomes, c) quality of life and cognitive functional outcomes, and d) survival. In addition, the utility of putative biomarkers to predict short and long-term outcomes will be assessed. The extension will insure the statistical power and the significance of the study outcomes. The extension will insure the statistical power and significance of the study outcomes. The ASSESS AKI is comprised of three Participating Clinical Centers (PCCs) and a data Coordinating Center. An additional site was added as an ancillary study in 2010.
Federal Grant Title: Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-12-509
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Digestive, and Kidney Diseases Extramural Research
Current Application Deadline: Nov 21, 2012
Original Application Deadline: Nov 21, 2012
Posted Date: August 30th, 2012
Creation Date: Aug 30, 2012
Archive Date: Dec 22, 2012
Total Program Funding: $2,200,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not A...
NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core ...
Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Al...
(Re)Building a Kidney (UC2 Clinical Trial Not Allowed)
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com